Clinical Trials Search Tool

A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants with Early Alzheimer’s Disease

Disease/Condition: Alzheimer’s disease

Location: Portland

Ages: 50-85

Enrollment Opens: 04-01-2022

Enrollment Closes: TBD


This trial is called the INVOKE-2 trial, and is sponsored by Alector Inc. in collaboration with AbbVie. For more information please see

Study ID: AL002

To Enroll: Call 503-476-9788 or schedule your free over-the-phone memory screen here:

Posted by: Center for Cognitive Health |